Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma

Abstract Identifying novel prognostic biomarkers for hepatocellular carcinoma (HCC) and then, develop an effective individualized treatment strategy remain extremely warranted. The prognostic role of sulfiredoxin‐1(SRXN1), an antioxidant enzyme, remains unknown in HCC. This study aimed to explore th...

Full description

Bibliographic Details
Main Authors: Qian‐Wen Rao, Shi‐Long Zhang, Meng‐Zhou Guo, Fei‐Fei Yuan, Jia‐Lei Sun, Feng Qi, Li‐Shun Wang, Bi‐Wei Yang, Jing‐Lin Xia
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Cancer Medicine
Subjects:
Hepatocellular carcinoma
nomogram
prognosis
Sulfiredoxin‐1
survival analysis
Online Access:https://doi.org/10.1002/cam4.3430

Internet

https://doi.org/10.1002/cam4.3430

Similar Items